Jaguar Health, Inc. (NASDAQ:JAGX)

BRIEF

published on 01/22/2025 at 15:05, 1 year ago

Jaguar Health Begins Trial for Crofelemer in Treating Rare Diseases

Jaguar Health Orphan Drug Designation MVID Crofelemer Trial SBS-IF
PRESS RELEASE

published on 01/22/2025 at 15:00, 1 year ago

Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025
Sheikh Khalifa Medical City hosts Jaguar Health's crofelemer trial for MVID & SBS-IF. POC data aims to support early patient access in EU countries

Crofelemer Jaguar Health MVID SBS-IF Sheikh Khalifa Medical City
BRIEF

published on 01/10/2025 at 22:20, 1 year ago

Jaguar Health Announces Inducement Grants for New Employees

Jaguar Health Employee Grants Nasdaq Rule Stock Units RSU Vesting
PRESS RELEASE

published on 01/10/2025 at 22:15, 1 year ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. granted RSUs to new employees, with vesting over one to three years. The RSUs were approved by Jaguar's Compensation Committee

Restricted Stock Units Jaguar Health Vesting RSUs New Employees
BRIEF

published on 01/08/2025 at 14:35, 1 year ago

Jaguar Health to Present at Upcoming Investor Events

Biotech Showcase Pharmaceuticals Jaguar Health Fireside Chat Investor Events
PRESS RELEASE

published on 01/08/2025 at 14:30, 1 year ago

Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
Jaguar Health, Inc. to participate in virtual fireside chat and in-person presentation at upcoming healthcare events. Focus on developing medicines from rainforest plants

Pharmaceuticals Jaguar Health Rainforest Plants Virtual Fireside Chat Healthcare Events
BRIEF

published on 01/07/2025 at 16:05, 1 year ago

Magdalena Biosciences Set to Present at Neuroscience Innovation Forum

ADHD Magdalena Biosciences Schizophrenia Botanical Drugs MB2500
PRESS RELEASE

published on 01/07/2025 at 16:00, 1 year ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena plans to file IND for new psychoactive drug in 2025 for mental health, focusing on ADHD and schizophrenia. Potential paradigm shift in plant-based drug development

ADHD Schizophrenia IND Application Magdalena Psychoactive Drug
BRIEF

published on 12/19/2024 at 15:05, 1 year 1 month ago

Jaguar Health's Joint Venture Imports Coca Leaf for Mental Health Research

Jaguar Health Botanical Drugs Coca Leaf Import Mental Health Research ADHD Treatments
PRESS RELEASE

published on 12/19/2024 at 15:00, 1 year 1 month ago

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications
Magdalena explores coca leaf's therapeutic benefits for ADHD and neuropsychiatric indications in partnership with Peru. Jaguar's Dr. King to present at Wisdom of the Leaf Coca Summit on coca-based Botanical Drugs

ADHD Peru Botanical Drugs Magdalena Coca Leaf

Published on 01/30/2026 at 08:00, 16 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 6 hours 1 minute ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 8 hours 16 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 9 hours 16 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 13 hours 31 minutes ago

Silver Spruce Appoints Vice-President of Exploration

View all ACCESSWIRE

Published on 01/30/2026 at 08:00, 15 minutes ago

Ørsted to present its annual report for 2025 on February 6
Published on 01/30/2026 at 08:00, 15 minutes ago

Transaction in Own Shares
Published on 01/30/2026 at 08:00, 15 minutes ago

Aquis Stock Exchange: Admission to trading
Published on 01/30/2026 at 07:29, 46 minutes ago

Consolidated profit (excluding Russia) above 1.4 billion euros
Published on 01/30/2026 at 07:00, 1 hour 15 minutes ago

Unbroken record series with high revenue momentum for cloud and subscriptions – 20th record year in a row for revenue and earnings

View all EQS

Published on 01/30/2026 at 08:00, 16 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 14 hours 16 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 14 hours 31 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 14 hours 31 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 14 hours 36 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News